IMR Press / CEOG / Volume 44 / Issue 2 / DOI: 10.12891/ceog3474.2017

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Assessment of 8-hydroxydeoxyguanosine levels in patients with preeclampsia: a prospective study
Show Less
1 Gaziantep University, School of Medicine, Dpt. of Obstetrics and Gynecology, Gaziantep, Turkey
2 Medipol University, School of Medicine, Dpt. of Obstetrics and Gynecology, Istanbul, Turkey
3 Gaziantep University, School of Medicine, Dpt. of Biochemistry, Gaziantep, Turkey
4 Gaziantep Cengiz Gokcek Maternity Hospital, Dpt. of Obstetrics and Gynecology/Gaziantep, Turkey
Clin. Exp. Obstet. Gynecol. 2017, 44(2), 226–229;
Published: 10 April 2017

Purpose of investigation: To determine the levels of 8-hydroxydeoxyguanosine (8-OHdG) in preeclampsia (PE) using (enzymelinked immunosorbent assay (ELISA) method. Materials and Methods: Twenty-two pregnant women with severe PE, 18 pregnant women with mild PE, and 40 healthy pregnant women, all between 25 and 41 weeks of gestation, were enrolled in this prospective controlled study. 8-OHdG levels in maternal serum were measured using ELISA method. Results: The authors observed no statistically significant difference in 8-OHdG levels between the mild-severe PE and control groups (p = 0.208). Conclusion: The present results do not support the concept that 8-OHdG has a role in the etiopathogenesis of PE.
Oxidative stress
Back to top